Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Explore well capitalized crypto projects and understand how solid treasury reserves contribute to long-term viability and growth.
19,258 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
ServiceNow has built a durable software platform with strong margins and steady growth. This article explains why the...
A Harvard professor decodes the squeak that haunts basketball courts, tying micro-deformations in the sole to the son...
As retirement tax planning evolves in 2026, a roth conversion strategy that pairs careful timing with residency moves...
Freddie Mac reports mortgage rates fall below 6% this week for the first time since 2022, signaling relief for buyers...
Iraq signals a possible exit from OPEC, fueling bets that a world rejecting opec controls could unleash softer oil pr...
eXp World Holdings plans to reincorporate from Delaware to Texas, with a stockholder vote slated at the annual meetin...
Snap co-founder Evan Spiegel and Miranda Kerr are funding a California medical debt relief program, potentially wipin...
A day of mixed signals, with Nvidia’s surge fading and tech shares pulling the Nasdaq and S&P 500 lower. Here’s what ...
Medicare Part B premiums and income-based IRMAA surcharges are reshaping retirement budgets in 2026. The typical reti...
An american hockey star plays in Ottawa pushes back after the White House shared an AI-doctored TikTok clip that misr...
U.S. corporations are accelerating stock repurchases, widening participation beyond mega-cap tech and triggering a br...